Precision of pre-sirt predictive dosimetry
|
|
- Norma Bell
- 6 years ago
- Views:
Transcription
1 International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY Precision of pre-sirt predictive dosimetry Hugo Levillain Department of Nuclear Medicine Medical Physics Jules Bordet Institute, Université Libre de Bruxelles Brussels, Belgium
2 Imaging workflow pre-sirt 1 Patient s Selection Diagnostic MRI, CT, PET/CT, SPECT/CT 2 Patient stratification Hepatobiliary scintigraphy Dynamic Planar + SPECT/CT 3 3D CT Angiogram Cone Beam CT (CBCT) 99m Tc-MAA injection 99m Tc-MAA SPECT/CT Treatment Planning Prevent post-therapy complication and select patient with good potential outcome 1
3 3 Imaging workflow post-sirt CBCT 90 Y SIR-Spheres injection 90 Y SIR-Spheres PET/CT Treatment 7 to 15 days after simulation We see what We treat 4 Patients follow up 6-8 weeks after treatment Follow-up MRI, CT, PET/CT, SPECT/CT Response assessment 2
4 Personalized pre-sirt predictive dosimetry & SIRT therapeutic window Optimize the therapeutic efficacy Minimize the dose to organs at risk: Safety Maximize the dose delivered to the tumor 3
5 Problems Therapeutic window To be defined according to cutoffs definitions Which dosimetry methodology? Personalized pre-sirt predictive dosimetry Which dosimetry methodology? Predictive power? Precision and accuracy of pre-sirt predictive dosimetry 4
6 Problems Therapeutic window To be defined according to cutoffs definitions Which dosimetry methodology? Personalized pre-sirt predictive dosimetry Which dosimetry methodology? Predictive power? Precision and accuracy of pre-sirt predictive dosimetry 5
7 SIRT therapeutic window: therapeutic effect Progressive disease Threshold for response Response Partial Response / Stable disease SIRsphere Therasphere Cremonesi et al., 2014, frontiers in Oncology 6
8 TLG change % SIRT therapeutic window: therapeutic effect Dose-response relationship based on 99m Tc-MAA SPECT/CT for mcrc patients Flamen et al. 2008: R² = Simulated Absorbed Dose (Gy) Significant response (ΔTLG>50%) for D mean > 66 Gy No standardization of image acquisition and reconstruction Evolution of image modalities Flamen P. et al. 2008, Physics in Medicine and Biology 7
9 Problems Therapeutic window To be defined according to cutoffs definitions Which dosimetry methodology? Personalized pre-sirt predictive dosimetry Which dosimetry methodology? Predictive power? Precision and accuracy of pre-sirt predictive dosimetry 8
10 Dosimetry methodology Medical Internal Radiation Dose (MIRD) formalism Procedure guidelines based on MIRD model Cumulated Activity (biological data): 3D quantification S Factor (Physical data): Energy deposition into target volume Organ/sub-organ level Hypothesis: uniform distribution Bolch.W. et al. 2009, Journal of nuclear medicine : official publication, Society of Nuclear Medicine 9
11 Dosimetry methodology Personalized 3D dosimetry (Planet Onco 3.0, Dosisoft ) MIRD at voxel scale Time Integrated Activity (TIA) map at voxel scale Voxel S values (VSV) (Dieudonne et al., 2011) Dieudonné, A., 2011, Journal of Nuclear Medicine 10
12 Dosimetry methodology Personalized 3D dosimetry (Planet Onco 3.0, Dosisoft ) 90 Y SIR-Spheres PET/CT 99m Tc-MAA SPECT/CT 90 Y SIR-Spheres isodoses Convert to 90 Y-MS TIA map VSV Dose Volume Histogram (DVH) Dieudonné, A., 2011, Journal of Nuclear Medicine 11
13 Dosimetry methodology Personalized 3D dosimetry: Dose Volume Histograms 40 Gy 100% uniform 40 Gy 60% uniform 40 Gy 60% Heterogeneous 00 V (%) D (Gy)
14 Dosimetry methodology Personalized 3D dosimetry: Dose Volume Histograms 40 Gy 100% uniform 40 Gy 60% uniform 40 Gy 60% Heterogeneous 00 V (%) D (Gy)
15 Dosimetry methodology Personalized 3D dosimetry: Dose Volume Histograms 40 Gy 100% uniform 40 Gy 60% uniform 40 Gy 60% Heterogeneous 00 V (%) D (Gy)
16 Dosimetry methodology Jules Bordet Institute s pre-sirt dosimetry workflow I) Images selection 99m Tc-MAA SPECT/ CT (reference images) Diagnostic images (FDG PET/CT, SPECT CT, IRM, CT) Additional images: CBCT, hepatobiliary SPECT/CT 13
17 Dosimetry methodology Jules Bordet Institute s pre-sirt dosimetry workflow II) 99m Tc-MAA SPECT/ CT Liver delineation Manually Errors 14
18 Dosimetry methodology Jules Bordet Institute s pre-sirt dosimetry workflow III) Images rigid co-registration Automatic + visual inspection and manual corrections Errors 15
19 Dosimetry methodology Jules Bordet Institute s pre-sirt dosimetry workflow IV) 99m Tc-MAA treated liver delineation (e.g. right liver) Manually Validation with CBCT Errors 16
20 Dosimetry methodology Jules Bordet Institute s pre-sirt dosimetry workflow V)Lesions delineation Fixed threshold based on PERCIST Errors Wahl.R. et al., 2009, Journal of Nuclear Medicine 17
21 Dosimetry methodology Jules Bordet Institute s pre-sirt dosimetry workflow V (%) VI) Dosimetry using partition model 1) Safety Activity homogenous MAA distribution giving 40 Gy to the treated liver Prescribed activity = 987 MBq Lesion mean absorbed dose = 288 Gy D (Gy) 18
22 Dosimetry methodology Jules Bordet Institute s pre-sirt dosimetry workflow VI) Dosimetry: Personalized 3D dosimetry (Planet Onco 3.0, Dosisoft ) 2) Optimization Dose volume histogram based Activity giving 40% of the treated liver receive less than 40 Gy EBRT safety criteria transformed using BED Before optimization 35 Gy-40% After optimization 40 Gy-40%
23 Dosimetry methodology Jules Bordet Institute s pre-sirt dosimetry workflow VI) Dosimetry: Personalized 3D dosimetry (Planet Onco 3.0, Dosisoft ) 2) Validation Lesion mean absorbed dose = 339 Gy (+50 Gy) Prescribed activity Simulation 99m Tc-MAA isodoses on baseline FDG PET/CT 20
24 Dosimetry methodology Jules Bordet Institute s pre-sirt dosimetry workflow Pre-SIRT predictive dosimetry Minimize the dose to the liver Maximize the dose delivered to the tumor Personalized activity prescription 21
25 Problems Therapeutic window To be defined according to cutoffs definitions Which dosimetry methodology Personalized pre-sirt predictive dosimetry Which dosimetry methodology Predictive power? Precision and accuracy of pre-sirt predictive dosimetry 22
26 Pre-SIRT dosimetry errors sources Biology Vascularization Hemodynamics Dosimetry MAA as a surrogate of microspheres distribution? Same catheter position? Dosimetry methodology Prepared vs prescribed activities? Administered vs prescribed activities? SIRT needs precise/accurate determination of administered 90 Y SIR-Spheres activity 23
27 Response Side effects Response Side effects Precision and accuracy of pre-sirt dosimetry SIRT needs accurate/precise determination of administered 90 Y SIR-Spheres activity Affected by Stochastic and Systematic errors Systematic Accuracy Stochastic Precision Clinical dosimetry need first Precision 24
28 Response Side effects Precision and accuracy of pre-sirt dosimetry Dealing with accuracy No gold-standard applicable in clinical routine Expensive Radionuclide calibrator and/or sources transport for calibration Cross-validation of radionuclide calibrator with 90 Y SIR-Spheres PET/CT s calibration Constant 4 25
29 Quality assurance of activity administration in SIRT Evaluate the difference between administered 90Y SIR-Spheres activities: Computed A prepared A residual Quantified on 90 Y PET/CT images 26
30 Quality assurance of activity administration in SIRT Retrospective study based on 73 patients Single catheter position No quantifiable shunt to non-target organs Patients underwent 99m Tc-MAA SPECT/CT MAA perfusion volume (1-5% max) Activity prescription 90 Y SIR-Spheres PET/CT 27
31 Quality assurance of activity administration in SIRT Administered activity Computed (State of the art): A prepared A residual 1 Quantified on 90 Y PET/CT Corrected from nuclear decay 2 28
32 Quality assurance of activity administration in SIRT 1 Computed administered activity A prepared A residual 90 Y SIR-Spheres activity to inject Prepared in accordance to the prescription Measured with radionuclide calibrator CRC-15R Capintec Residual activity Pre/Post-injection box doses rates measurements 29
33 Quality assurance of activity administration in SIRT 2 Quantified administered activity 90 Y SIR-Spheres PET/CT images GE-Healthcare Discovery 690 PET/CT 2 bed positions of 30min, voxel size: mm 3 Images reconstruction (QUEST phantom study) 3D OSEM, 18 iterations, 3 subsets, 13.7 Gaussian post-filtering Corrections: Attenuation, Diffusion, TOF, PSF inhomogeneity Willowson.K. et al., 2015, European Journal of Nuclear Medicine and Molecular Imaging 30
34 Quality assurance of activity administration in SIRT Quantified administered activity 2 Requires a volume 90 Y SIR-Spheres PET/CT volume delineation? No methods Noise Partial volume effect Utilize the MAA volume 90 Y SIR-Spheres PET/CT quantification Predictive power of MAA for the volume Willowson.K. et al., 2015, European Journal of Nuclear Medicine and Molecular Imaging Carlier.T. et al., 2016, Medical Physics 31
35 Quality assurance of activity administration in SIRT Quantified administered activity 2 Registration corrected by visual inspection 32
36 Quality assurance of activity administration in SIRT Quantified vs Computed administered activities Univariate linear regression Agreement between computed and quantified activities Relative difference between the 2 measurements Mean ± SD Plot of errors as a function of treated volume size Plot of errors as a function of the amount of injected activity 33
37 Quantified 90 Y-MS activity (MBq) Quality assurance of activity administration in SIRT Quantified vs Computed administered activities R 2 =0.96 Computed 90 Y-MS activity (MBq) 34
38 Frequency Quality assurance of activity administration in SIRT Quantified vs Computed administered activities Mean relative difference=3.2±12.3% Relative difference (%) 35
39 Relative difference (%) Relative difference (%) Quality assurance of activity administration in SIRT Quantified vs Computed administered activities Treated Volume (cm3) Administered activity (MBq) 36
40 Problems Therapeutic window To be defined according to cutoffs definitions Which dosimetry methodology Personalized pre-sirt predictive dosimetry Which dosimetry methodology Predictive power Precision and accuracy of pre-sirt predictive dosimetry 37
41 Conclusion Relative difference between computed and quantified administered activities is relatively low Good correlation of the 2 measurements: R 2 = 0.96, mean relative difference = 3.2 ± 12.3% Knowledge of the precision of the correlation Importance of images registration and segmentation No correlation with the amount of injected activity or with treated volume size 38
42 Conclusion Feasibility of a quality assurance process 90 Y SIR-Spheres PET/CT can be used directly to measure the administered activity Demonstration of the predictive power of pre-sirt predictive dosimetry at liver scale 39
43 Perspectives 90 Y-MS PET/CT and 99m Tc-MAA distributions correlation Simulation 99m Tc-MAA isodoses On baseline FDG PET/CT Treatment 90 Y SIR-Spheres isodoses On baseline FDG PET/CT 40
44 Take home message Therapeutic Window Predictive dosimetry : treatment outcome optimization Personalized 3D Dosimetry workflow Volume delineation and image registration Safety: 40 Gy to the treated volume Optimization: 40 Gy 40% based on DVH Validation Personalized activity prescription 41
45 International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY Thank you!
8/1/2017. Disclosures. Outline. SAM Imaging Education Course 90Y-Microsphere Therapy: Emerging Trends and Future Directions
SAM Imaging Education Course Y-Microsphere Therapy: Emerging Trends and Future Directions Matt Vanderhoek, PhD Henry Ford Health System, Detroit, MI Vanessa Gates, MS Northwestern University, Chicago,
More informationCalculation methods in Hermes Medical Solutions dosimetry software
Calculation methods in Hermes Medical Solutions dosimetry software Helena McMeekin MSc. Clinical Applications Scientist, Hermes Medical Solutions MRTDosimetry Scientific Workshop The Principals and Clinical
More informationTheranostics in Nuclear Medicine
Theranostics in Nuclear Medicine Patrick FLAMEN, MD, PhD Head Nuclear Medicine Institut Jules Bordet Université Libre de Bruxelles (U.L.B.) n Theranostics in Nuclear Medicine n A form of (nuclear) diagnostic
More informationY90 SIRT Therapy Dosimetric Aspects
Y90 SIRT Therapy Dosimetric Aspects David Chee-Eng Ng MBBS, BSc, MSc, MRCP, FAMS, FRCP (Edin) Head and Senior Consultant, Department of Nuclear Medicine and PET Singapore General Hospital Adjunct Assistant
More informationLu-DOTATATE PRRT dosimetry:
177 Lu-DOTATATE PRRT dosimetry: From theory to practice Silvano Gnesin Medical Physics department Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Switzerland Gwennaëlle Marin Medical
More informationThe Clinical Utility of Yttrium-90 PET after SIRT
The Clinical Utility of Yttrium-90 PET after SIRT Dr Yung Hsiang Kao Department of Nuclear Medicine Austin Health Melbourne, Australia 2 nd Asia Pacific Symposium on Liver-Directed Y-90 Microspheres Therapy
More informationQuantifying Y-90 PET. The Challenges Associated With the QUEST Study. Michael Tapner Research & Development Project Manager Sirtex
Quantifying Y-90 PET. The Challenges Associated With the QUEST Study Michael Tapner Research & Development Project Manager Sirtex Internal Dosimetry with 90 Y Resin Microspheres: QUEST COUNT MAP ACTIVITY
More informationClinical Implementation of patient-specific dosimetry, comparison with absorbed fraction-based method
Clinical Implementation of patient-specific dosimetry, comparison with absorbed fraction-based method George Sgouros, Ph.D. Russell H. Morgan Dept of Radiology & Radiological Science Johns Hopkins University,
More informationSORAMIC: NM Procedures
: NM Procedures J. Ruf Klinik für Radiologie und Nuklearmedizin : NM Procedures Evaluation - 99m Tc MAA Scintigraphy Lung shunt assessment Treatment activity determination Therapy - 90 Y-SIR-Spheres Procedure
More informationDosimetry and radiobiology for Peptide Receptor Radionuclide Therapy
Dosimetry and radiobiology for Peptide Receptor Radionuclide Therapy Short-ranged particle emitters for targeted radionuclide therapy require specific dosimetry and radiobiology Mark Konijnenberg Melodi
More informationQuantitative Theranostics in Nuclear Medicine
Quantitative Theranostics in Nuclear Medicine M. Lassmann Klinik und Poliklinik für Nuklearmedizin Direktor: Prof. Dr. A. Buck Contents What is Theranostics? Potential Targets Basic Principles of Quantitative
More informationSelective Internal Radiation Therapy. Jefferson R. Pagsisihan, MD, DPSNM The Medical City St. Luke s Medical Center
Selective Internal Radiation Therapy Jefferson R. Pagsisihan, MD, DPSNM The Medical City St. Luke s Medical Center S Selective Internal Radiation Therapy catheter-based liver directed modality for patients
More information7/13/2015. Current Trends in Yttrium-90 Microsphere Therapy Planning and Dosimetry. Educational Objectives TRANS-ARTERIAL LIVER-DIRECTED THERAPIES
Current Trends in Yttrium-90 Microsphere Therapy Planning and Dosimetry Armeen Mahvash, MD S. Cheenu Kappadath, PhD The University of Texas MD Anderson Cancer Center, Houston, Texas AAPM Annual Meeting
More informationFacilitating Lu 177 Personalized Dosimetry for Neuroendocrine Tumours CANM 2017
Facilitating Lu 177 Personalized Dosimetry for Neuroendocrine Tumours CANM 2017 CANM ANNUAL SCIENTIFIC MEETING APRIL 20-23, 2017 TORONTO, ONTARIO I do not have a financial interest, arrangement or affiliation
More informationSIRT Dosimetry: Sometimes Less Is More
SIRT Dosimetry: Sometimes Less Is More Navesh K. Sharma, DO, PhD Assistant Professor, Departments of Radiation Oncology, Diagnostic Radiology and Nuclear Medicine Medical Director, Radiation Oncology,
More informationA. DeWerd. Michael Kissick. Larry. Editors. The Phantoms of Medical. and Health Physics. Devices for Research and Development.
Larry Editors A. DeWerd Michael Kissick The Phantoms of Medical and Health Physics Devices for Research and Development ^ Springer Contents 1 Introduction to Phantoms of Medical and Health Physics 1 1.1
More informationIsoeffective Dose Specification of Normal Liver in Yttrium-90 Microsphere Radioembolization*
Isoeffective Dose Specification of Normal Liver in Yttrium-90 Microsphere Radioembolization* Barry W. Wessels, Ph.D 1 ; Amilia G. Di Dia, PhD 2 ;Yiran Zheng, PhD 1 Marta Cremonesi, PhD 2 1 University Hospitals
More informationIART and EBRT, an innovative approach
External beam radiotherapy and nuclear medicine therapy: which kind of integration? Mahila Ferrari mahila.ferrari ferrari@ieo.it A different NM and RT integration... Radionuclide therapy combined to EBRT
More informationBORDET DEPARTMENT RADIATION ONCOLOGY
BORDET DEPARTMENT RADIATION ONCOLOGY The Radiation Oncology Department has been providing patients with high quality, tailored radiation oncology care for the last 60 years in a multidisciplinary setting
More informationChapters from Clinical Oncology
Chapters from Clinical Oncology Lecture notes University of Szeged Faculty of Medicine Department of Oncotherapy 2012. 1 RADIOTHERAPY Technical aspects Dr. Elemér Szil Introduction There are three possibilities
More information8/2/2018. Disclosure. Online MR-IG-ART Dosimetry and Dose Accumulation
Online MR-IG-ART Dosimetry and Dose Accumulation Deshan Yang, PhD, Associate Professor Department of Radiation Oncology, School of Medicine Washington University in Saint Louis 1 Disclosure Received research
More information8/10/2016. PET/CT Radiomics for Tumor. Anatomic Tumor Response Assessment in CT or MRI. Metabolic Tumor Response Assessment in FDG-PET
PET/CT Radiomics for Tumor Response Evaluation August 1, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu Anatomic Tumor Response Assessment
More informationWhat do we Know About Adaptive Radiotherapy? Lei Dong, Ph.D. Scripps Proton Therapy Center San Diego, California
What do we Know About Adaptive Radiotherapy? Lei Dong, Ph.D. Scripps Proton Therapy Center San Diego, California AAMD Region II Meeting Houston, Texas September 13-14, 2012 Learning Objectives To gain
More informationPatient dosimetry for 90 Y selective internal radiation treatment based on 90 Y PET imaging
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 5, 2013 Patient dosimetry for 90 Y selective internal radiation treatment based on 90 Y PET imaging Sherry C. Ng, 1a Victor H. Lee, 2 Martin
More informationFuture Needs for Standards in 90 Y Microsphere Therapy. CIRMS 2012 Reed Selwyn, PhD, DABR 24 October 2012
Future Needs for Standards in 90 Y Microsphere Therapy CIRMS 2012 Reed Selwyn, PhD, DABR 24 October 2012 Objectives I. General Description Microsphere Distribution Product Comparison II. Dosimetry Models
More informationStereotaxy. Outlines. Establishing SBRT Program: Physics & Dosimetry. SBRT - Simulation. Body Localizer. Sim. Sim. Sim. Stereotaxy?
Establishing SBRT Program: Physics & Dosimetry Lu Wang, Ph.D. Radiation Oncology Department Fox Chase Cancer Center Outlines Illustrate the difference between SBRT vs. CRT Introduce the major procedures
More informationDosimetry (Dose Estimation) of Internal Emitters. Outline. For Radiation Effects, is Dose the only Answer? Estimation of Dose and not Dosimetry
Dosimetry (Dose Estimation) of Internal Emitters. Lawrence E. Williams, PhD City of Hope National Medical Center Duarte CA 91010 lwilliams@coh.org Outline 1. Dose Estimation Formula D = S*Ã 2. Determination
More informationReview of TG-186 recommendations
Review of TG-186 recommendations Implementation of advanced brachytherapy dose calculation algorithms beyond TG-43 Rowan M. Thomson Carleton Laboratory for Radiotherapy Physics Carleton University Ottawa
More informationBiases affecting tumor uptake measurements in FDG-PET
Biases affecting tumor uptake measurements in FDG-PET M. Soret, C. Riddell, S. Hapdey, and I. Buvat Abstract-- The influence of tumor diameter, tumor-tobackground activity ratio, attenuation, spatial resolution,
More informationUsing PET/MRI to Assess Hepatic Radioembolization of Yttrium-90 Microspheres
Washington University in St. Louis Washington University Open Scholarship Engineering and Applied Science Theses & Dissertations Engineering and Applied Science Spring 5-15-2017 Using PET/MRI to Assess
More informationAdvanced quantification in oncology PET
Advanced quantification in oncology PET Irène Buvat IMNC UMR 8165 CNRS Paris 11 University Orsay, France buvat@imnc.in2p3.fr http://www.guillemet.org/irene ISSSMA 2013 - June 3rd 2013-1 Two steps Static
More informationDosimetry Optimization System and Integrated Software (DOSIS): a comparison against Fluka code results over a standard phantom
Dosimetry Optimization System and Integrated Software (DOSIS): a comparison against Fluka code results over a standard phantom Institute of Physics E. Gaviola - CONICET & LIIFAMIRX - Laboratorio de Investigación
More informationQuantitative Imaging: A hospital physicist s perspective James Scuffham
Quantitative Imaging: A hospital physicist s perspective James Scuffham Clinical Scientist, Royal Surrey County Hospital NHS Foundation Trust Associate Tutor, University of Surrey Background The Royal
More informationBackground. New Cross Hospital is a 700 bed DGH located in central England
Background New Cross Hospital is a 700 bed DGH located in central England Regional Heart & Lung centre opened in 2005 Covering the Black Country (Population >1,000,000) Nuclear Medicine Department Single
More informationMetabolic volume measurement (physics and methods)
Metabolic volume measurement (physics and methods) Ronald Boellaard Department of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam r.boellaard@vumc.nl Metabolic volume vs tumor
More informationUse of imaging systems for patient modeling - PET and SPECT
Use of imaging systems for patient modeling - PET and SPECT Sasa Mutic Department of Radiation Oncology Siteman Cancer Center Mallinckrodt Institute of Radiology Washington University School of Medicine
More informationInternational Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY
International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY A Joint Initiative of IAEA BELNUC - JULES BORDET INSTITUTE OCTOBER 2-6, 2017 Venue: Auditorium Tagnon Jules Bordet Institute Boulevard de
More informationSELECTIVE INTERNAL RADIATION THERAPY FOR TREATMENT OF LIVER CANCER
SELECTIVE INTERNAL RADIATION THERAPY FOR TREATMENT OF LIVER CANCER SIR-Spheres*: A New Treatment Option for Non-Resectable Liver Tumors Treatment Overview SIRT: Selective Internal Radiation Therapy Concept
More informationStandardization of Radiopharmaceutical Dosimetry
Standardization of Radiopharmaceutical Dosimetry Jonathon A. Nye, PhD Department of Radiology and Imaging Sciences Emory University SEAAPM 2011 Myrtle Beach, SC Review of Dosimetry Nomenclature Dose Gray
More informationAn audit of radiation dose of 4D CT in a radiotherapy department
An audit of radiation dose of 4D CT in a radiotherapy department Poster No.: R-0097 Congress: Type: Authors: Keywords: DOI: 2014 CSM Scientific Exhibit T. Hubbard, J. Callahan, J. Cramb, R. Budd, T. Kron;
More informationThe IAEA BSS and development of an international dosimetry protocol
The BSS and development of an international dosimetry protocol MetroMRT 3 rd Workshop National Physical Laboratory, Teddington, UK 20-21 April 2015 Gian Luca POLI International Atomic Energy Agency Dosimetry
More informationPhysical Bases : Which Isotopes?
Physical Bases : Which Isotopes? S. Gnesin Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Switzerland 1/53 Theranostic Bruxelles, 2 Octobrer 2017 Theranostic : use of diagnostic
More informationApplication of 3D Printing to Molecular Radiotherapy Phantoms. Nick Calvert Nuclear Medicine Group The Christie NHS Foundation Trust, Manchester
Application of 3D Printing to Molecular Radiotherapy Phantoms Nick Calvert Nuclear Medicine Group The Christie NHS Foundation Trust, Manchester Molecular Radiotherapy Radionuclide administered to patient
More informationSilvia Pella, PhD, DABR Brian Doozan, MS South Florida Radiation Oncology Florida Atlantic University Advanced Radiation Physics Boca Raton, Florida
American Association of Medical Dosimetrists 2015 Silvia Pella, PhD, DABR Brian Doozan, MS South Florida Radiation Oncology Florida Atlantic University Advanced Radiation Physics Boca Raton, Florida Most
More informationPET in Radiation Therapy. Outline. Tumor Segmentation in PET and in Multimodality Images for Radiation Therapy. 1. Tumor segmentation in PET
Tumor Segmentation in PET and in Multimodality Images for Radiation Therapy Wei Lu, Ph.D. Department of Radiation Oncology Mallinckrodt Institute of Radiology Washington University in St. Louis Outline
More informationNIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning
NIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD Dosimetry Planning CPT Codes: 77295, 77300, 77301, 77306, 77307, 77321, 77316, 77317, 77318, 77331, 77399 Original Date: April, 2011 Last Reviewed
More informationThe Management of Imaging Procedure Dose Nuclear Medicine Dose Indices
The Management of Imaging Procedure Dose Nuclear Medicine Dose Indices Wesley E. Bolch, PhD, PE, DABHP, FHPS, FAAPM Director, Advanced Laboratory for Radiation Dosimetry Studies Department of Biomedical
More informationThe impact of dose prescription on treatment volume
The impact of dose prescription on treatment volume Summer Chaudhari 1 st year medical physics resident University of Minnesota Medical Center Advisor: Dr. Patrick Higgins NCCAAPM chapter meeting April
More informationOutline. Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) SPECT/CT and PET/CT Dosimetry
SPECT/CT and PET/CT Dosimetry Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) All Solid Tumors Leukemia Frederic H. Fahey DSc Male Female Male Female Children s Hospital Boston
More informationTypical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?
Typical PET Image Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located? PET/CT Oncology Imaging Anatometabolic fusion images are useful in the management
More informationDefining Target Volumes and Organs at Risk: a common language
Defining Target Volumes and Organs at Risk: a common language Eduardo Rosenblatt Section Head Applied Radiation Biology and Radiotherapy (ARBR) Section Division of Human Health IAEA Objective: To introduce
More informationKnowledge-Based IMRT Treatment Planning for Prostate Cancer: Experience with 101. Cases from Duke Clinic. Deon Martina Dick
Knowledge-Based IMRT Treatment Planning for Prostate Cancer: Experience with 101 Cases from Duke Clinic by Deon Martina Dick Department of Medical Physics Duke University Date: Approved: Joseph Lo, Chair
More information+ Radioembolization for ColoRectal Cancer Metastatic to the Liver
+ Radioembolization for ColoRectal Cancer Metastatic to the Liver Oct 4 th 2017 Alain Hendlisz, Institut Jules Bordet 1 st International Course on THERANOSTICS & MOLECULAR RADIOTHERAPY Indication and Rationale
More informationRanking radiotherapy treatment plans: physical or biological objectives?
Ranking radiotherapy treatment plans: physical or biological objectives? Martin Ebert Department of Radiation Oncology, Sir Charles Gairdner Hospital, Western Australia, Australia Background. The ranking
More informationRepeatability and reproducibility of 18 F-NaF PET quantitative imaging biomarkers
Repeatability and reproducibility of 18 F-NaF PET quantitative imaging biomarkers Christie Lin, Tyler Bradshaw, Timothy Perk, Stephanie Harmon, Glenn Liu, Robert Jeraj University of Wisconsin Madison,
More informationAustin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)
Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate) Overview Ga-68 dotatate binds to somatostatin receptors, with highest affinity for subtype 2 receptors (sstr2). It binds to cells that express
More informationSIR-Spheres: Des essais cliniques à la pratique courante
SIR-Spheres: Des essais cliniques à la pratique courante Un focus sur le traitement du mcrc en échappement thérapeutique Dr. Michaël Vouche, MD. PhD. Université Libre de Bruxelles Institut Jules Bordet
More informationRADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident
Resident s Name: RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident Rotation: PHYS 703: Clinical Rotation 2 Inclusive dates of rotation: Feb. 26, 2016 Aug. 25, 2016 Director or Associate
More informationDose Estimates for Nuclear Medicine Procedures: What are they? Where do they come from?
Dose Estimates for Nuclear Medicine Procedures: What are they? Where do they come from? SNM Continuing Education Lecture Salt Lake City, UT -- June 6, 2010 Darrell R. Fisher Pacific Northwest National
More informationQuality and Safety of Patient Healthcare and Personalized Medicine Using Ionizing Radiation
Quality and Safety of Patient Healthcare and Personalized Medicine Using Ionizing Radiation Ana Catarina Antunes, Mariana Baptista, Ana Belchior, Jorge Borbinha, Salvatore di Maria, Célia Fernandes, Joana
More informationEvaluation of yttrium-90 positron emission tomography dosimetry
Purdue University Purdue e-pubs Open Access Dissertations Theses and Dissertations Fall 2014 Evaluation of yttrium-90 positron emission tomography dosimetry Katherine N. Tapp Purdue University Follow this
More informationPreview of Presentation
Preview of Presentation Discuss Healthcare Environment Clinical Implementation of Technical Innovations SNMMI/ASNC Joint Statement on Rb-82 Cardiac PET Imaging Protocol Principles of Rb-82 Cardiac Imaging
More informationUse Of MCNP With Voxel-Based Image Data For Internal Dosimetry Applications
Use Of MCNP With Voxel-Based Image Data For Internal Dosimetry Applications The Monte Carlo Method: Versatility Unbounded In A Dynamic Computing World Chattanooga, TN, USA, April 17-21, 2005 M. G. Stabin
More informationDosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer
Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer Tan Chek Wee 15 06 2016 National University Cancer Institute, Singapore Clinical Care Education Research
More informationErasmus Experience. Lu-DOTA-octreotate PRRT
Erasmus Experience 177 Lu-DOTA-octreotate PRRT Mark Konijnenberg Erasmus MC, Rotterdam, Netherlands METRO/MRT meeting 2015, NPL, Teddington Leading questions? 1. For which MRT procedure dosimetry is used?
More informationImage Fusion, Contouring, and Margins in SRS
Image Fusion, Contouring, and Margins in SRS Sarah Geneser, Ph.D. Department of Radiation Oncology University of California, San Francisco Overview Review SRS uncertainties due to: image registration contouring
More informationY-90 Microsphere Therapy: Nuclear Medicine Perspective
Y-90 Microsphere Therapy: Nuclear Medicine Perspective Carl Hoh, M.D. Dept. Radiology UCSD Medical Center ckhoh@ucsd.edu Learning Objectives Role of Nuclear Medicine in patient selection Technical Issues
More informationReport of ICRU Committee on Volume and Dose Specification for Prescribing, Reporting and Recording in Conformal and IMRT A Progress Report
Report of ICRU Committee on Volume and Dose Specification for Prescribing, Reporting and Recording in Conformal and IMRT A Progress Report Paul M. DeLuca, Jr. 1, Ph.D., Vincent Gregoire 2, M.D., Ph.D.,
More informationPre-clinical radionuclide therapy dosimetry in several pediatric cancer xenografts
DEPARTMENT OF Medical Physics UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH Pre-clinical radionuclide therapy dosimetry in several pediatric cancer xenografts Ian R. Marsh A. Besemer MS
More informationLearning objective. Outline. Acknowledgements. KV CBCT Imaging Part I. R Hammoud AAPM 2008 CE-Therapy (SAM) 1
1 2 KV CBCT Imaging Part I Rabih Hammoud, MS, DABR Henry Ford Health System Detroit, Michigan Acknowledgements Indrin Chetty, PhD Teamour Nurushev, PhD Harrison Guan, PhD Jinkoo Kim, PhD JianYue Jin, PhD
More informationART for Cervical Cancer: Dosimetry and Technical Aspects
ART for Cervical Cancer: Dosimetry and Technical Aspects D.A. Jaffray, Ph.D. Radiation Therapy Physics Princess Margaret Cancer Centre/Techna/Ontario Cancer Institute Professor Departments of Radiation
More informationGastrointestinal tract
Gastrointestinal tract Colloidal liver-spleen imaging Presented by: Jehad Felemban Introduction: To obtain better anatomic display of liver and spleen architecture, we use (CT Ultrasound). (Radionuclide
More informationRadiation treatment planning in lung cancer
Radiation treatment planning in lung cancer Georg Dietmar 1,2 1 Div. Medical Rad. Phys., Dept. of Radiation Oncology / Medical Univ. Vienna & AKH Wien 2 Christian Doppler Laboratory for Medical Radiation
More informationManaging the imaging dose during Image-guided Radiotherapy. Martin J Murphy PhD Department of Radiation Oncology Virginia Commonwealth University
Managing the imaging dose during Image-guided Radiotherapy Martin J Murphy PhD Department of Radiation Oncology Virginia Commonwealth University Radiographic image guidance has emerged as the new paradigm
More informationPET-CT for radiotherapy planning in lung cancer: current recommendations and future directions
PET-CT for radiotherapy planning in lung cancer: current recommendations and future directions Gerry Hanna Centre for Cancer Research and Cell Biology Queen s University of Belfast @gerryhanna Talk Outline
More informationFrom position verification and correction to adaptive RT Adaptive RT and dose accumulation
From position verification and correction to adaptive RT Adaptive RT and dose accumulation Hans de Boer Move away from Single pre-treatment scan Single treatment plan Treatment corrections by couch shifts
More informationEN TERAPIA METAByLICA NO ESTrNDAR CON 177 Lu, 90 Y y 223 Ra
Jornada científica RADIOFuSICA DE LA DOSIMETRuA INTERNA EN LOS PROCEDIMIENTOS TERAPÉUTICOS CON RADIOFrRMACOS DOSIMETRIA FuSICA Y CLuNICA EN TERAPIA METAByLICA NO ESTrNDAR CON 177 Lu, 90 Y y 223 Ra Pablo
More informationPhoton Attenuation Correction in Misregistered Cardiac PET/CT
Photon Attenuation Correction in Misregistered Cardiac PET/CT A. Martinez-Möller 1,2, N. Navab 2, M. Schwaiger 1, S. G. Nekolla 1 1 Nuklearmedizinische Klinik der TU München 2 Computer Assisted Medical
More informationPROGRAMME Day 1. Friday 26 th October Session (presentation summaries attached) Speakers
PROGRAMME Day 1 Friday 26 th October Session (presentation summaries attached) Speakers 09:00 09:15 Summer School 2018 Welcome Julia Green 09:15 10:15 Session 1 Introduction (1.0hrs) 1.1 What a Quantitative
More informationGuideline & Reports 医学物理学会教育委員会資料
Guideline & Reports 医学物理学会教育委員会資料 2017/11 更新 report title year keyword 1 keyword 2 AAPM TG211 Classification and evaluation strategies of auto-segmentation approaches for PET 2017 PET autosegmentation
More informationCredentialing for Clinical Trials -IGRT. Evidence Based Radiation Oncology. Levels of Clinical Evidence. Why Credentialing?
Acknowledgements Credentialing for Clinical Trials -IGRT Invitation from Organizers RTOG Headquarter QA Team ATC Collaborators Evidence Based Radiation Oncology Clinical Trials From Collaborative Groups
More informationLeila E. A. Nichol Royal Surrey County Hospital
2 nd UK and Ireland Dosimetry Check User Meeting Symposium Clatterbridge Cancer Centre, 24 th October 2012 Leila E. A. Nichol Royal Surrey County Hospital Leila.Nichol@nhs.net *My experience with Dosimetry
More informationSPECT/CT image based dosimetry for Yttrium 90 radionuclide therapy: Application to treatment response
Received: 8 January 2018 Revised: 17 May 2018 Accepted: 29 May 2018 DOI: 10.1002/acm2.12400 RADIATION ONCOLOGY PHYSICS SPECT/CT image based dosimetry for Yttrium radionuclide therapy: Application to treatment
More informationImaging Rotation. University of Michigan Department of Radiation Oncology Division of Radiation Physics. Resident:
University of Michigan Department of Radiation Oncology Division of Radiation Physics Imaging Rotation Resident: Rotation staff mentor/ advisor: James Balter, supplemental mentors: Dale Litzenberg, Don
More informationSelection Criteria and Insertion of SIRT into HCC Treatment Guidelines
Selection Criteria and Insertion of SIRT into HCC Treatment Guidelines 2 nd Asia Pacific Symposium on Liver- Directed Y-90 Microspheres Therapy 1st November 2014, Singapore Pierce Chow FRCSE PhD SIRT in
More information3D Printed Phantoms for MRT Dosimetry
3D Printed Phantoms for MRT Dosimetry Dr. Andrew Robinson Nuclear Physics Group, The University of Manchester Christie Medical Physics and Engineering, The Christie NHS Foundation Trust BIR/IDUG: The Future
More informationHampton University Proton Therapy Institute
Hampton University Proton Therapy Institute Brief introduction to proton therapy technology, its advances and Hampton University Proton Therapy Institute Vahagn Nazaryan, Ph.D. Executive Director, HUPTI
More informationA Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer
A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer Tony Kin Ming Lam Radiation Planner Dr Patricia Lindsay, Radiation Physicist Dr John Kim, Radiation Oncologist Dr Kim Ann Ung,
More informationReal-time tumor tracking during VMAT radiotherapy treatments based on 2D/3D registration using CBCT projections
Real-time tumor tracking during VMAT radiotherapy treatments based on 2D/3D registration using CBCT projections Hugo Furtado 13, Yvette Seppenwoolde 23, Dietmar Georg 23, and Wolfgang Birkfellner 13 1
More informationSIRT in Neuroendocrine Tumors
SIRT in Neuroendocrine Tumors Marnix G.E.H. Lam, MD PhD Professor of Nuclear Medicine AVL Amsterdam UMC Utrecht ENETS Center of Excellence, The Netherlands Disclosure of speaker s interests Consultant
More informationRitu Raj Upreti, S. Dayananda, R. L. Bhalawat*, Girish N. Bedre*, D. D. Deshpande
60 Original Article Evaluation of radiograph-based interstitial implant dosimetry on computed tomography images using dose volume indices for head and neck cancer Ritu Raj Upreti, S. Dayananda, R. L. Bhalawat*,
More informationDosimetric Analysis Report
RT-safe 48, Artotinis str 116 33, Athens Greece RT-safe +30 2107563691 info@rt-safe.com Dosimetric Analysis Report SAMPLE, for demonstration purposes only Date of report: ------ Irradiation system: ------
More informationThe value of 99m Tc-MAA SPECT/CT for lung shunt estimation in 90 Y radioembolization: a phantom and patient study
Allred et al. EJNMMI Research (2018) 8:50 https://doi.org/10.1186/s13550-018-0402-8 ORIGINAL RESEARCH Open Access The value of 99m Tc-MAA SPECT/CT for lung shunt estimation in 90 Y radioembolization: a
More informationUtilisation du PET-FDG pour la définition des volumes cibles en radiothérapie des tumeurs de la sphère cervico-maxillo-faciale: mythe et réalité
Utilisation du PET-FDG pour la définition des volumes cibles en radiothérapie des tumeurs de la sphère cervico-maxillo-faciale: mythe et réalité Vincent GREGOIRE, M.D., Ph.D. Head and Neck Oncology Program,
More informationCURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT
CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT Purpose The purpose of this curriculum outline is to provide a framework for multidisciplinary training for radiation oncologists, medical
More informationQuality assurance and credentialing requirements for sites using inverse planned IMRT Techniques
TROG 08.03 RAVES Quality assurance and credentialing requirements for sites using inverse planned IMRT Techniques Introduction Commissioning and quality assurance of planning systems and treatment delivery
More information8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy
PET/CT for Tumor Response Evaluation August 4, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu FDG PET/CT for Cancer Imaging Staging and
More informationManaging the imaging dose during image-guided radiation therapy
Managing the imaging dose during image-guided radiation therapy Martin J Murphy PhD Department of Radiation Oncology Virginia Commonwealth University Richmond VA Imaging during radiotherapy Radiographic
More informationDose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83
Special report Dose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83 Rapid development in imaging techniques, including functional imaging,
More informationRadiosurgery by Leksell gamma knife. Josef Novotny, Na Homolce Hospital, Prague
Radiosurgery by Leksell gamma knife Josef Novotny, Na Homolce Hospital, Prague Radiosurgery - Definition Professor Lars Leksell The tools used by the surgeon must be adapted to the task and where the human
More information